Laddar...
Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations
For three decades, enzyme replacement therapy (ERT), and more recently, substrate reduction therapy, have been the standard-of-care for type I Gaucher disease (GD1). Since 2012, three different ERTs have been available. No clinical trial or academic study has ever compared these ERTs beyond one year...
Sparad:
| I publikationen: | Int J Mol Sci |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307068/ https://ncbi.nlm.nih.gov/pubmed/34299318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22147699 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|